Results 161 to 170 of about 1,304 (177)
Some of the next articles are maybe not open access.
The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
Journal of the Medical Association of Georgia, 1995Prolonged use of the nondepolarizing neuromuscular blocking agents in the critical care setting has greatly increased in the recent past. Accompanying the increased use of these agents are numerous accounts of long-lasting adverse outcomes such as muscular atrophy and neuropathy that can be attributed to pharmacologic paralysis.
J R, May, A F, Rutkowski
openaire +1 more source
Long-acting nondepolarizing neuromuscular blocking agents.
AANA journal, 1993Patients with compromised cardiovascular function who are undergoing cardiothoracic or other lengthy surgical procedures are at risk of complications from the hemodynamic effects of the long-acting nondepolarizing neuromuscular blocking agents (NMBs), which have been in use for several decades.
openaire +1 more source
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
Vecuronium provides additional flexibility to the clinician using neuromuscular‐blocking drugs. Its shorter duration of action, lack of significant cardiovascular effects and lack of dependence on the kidney for elimination provide clinical advantages over, or alternatives to, currently available, nondepolarizing neuromuscular‐blocking drugs.
openaire +2 more sources
Vecuronium provides additional flexibility to the clinician using neuromuscular‐blocking drugs. Its shorter duration of action, lack of significant cardiovascular effects and lack of dependence on the kidney for elimination provide clinical advantages over, or alternatives to, currently available, nondepolarizing neuromuscular‐blocking drugs.
openaire +2 more sources
THE PHARMACOLOGY OF NEW SHORT-ACTING NONDEPOLARIZING ESTER NEUROMUSCULAR BLOCKING AGENTS
Survey of Anesthesiology, 1973J J, Savarese +3 more
openaire +2 more sources
Canadian journal of anesthesia-Journal canadien d anesthesie, 1994
Three muscle relaxants, Org 9453, Org 9489 and Org 9487, short-acting in animals, were investigated to establish their profiles in humans. Potency, time course of action, and pharmacokinetic behaviour were studied in 90 healthy patients during fentanyl/halothane/N2O anaesthesia. Neuromuscular function was monitored mechanomyographically.
WIERDA, JMKH +4 more
openaire +1 more source
Three muscle relaxants, Org 9453, Org 9489 and Org 9487, short-acting in animals, were investigated to establish their profiles in humans. Potency, time course of action, and pharmacokinetic behaviour were studied in 90 healthy patients during fentanyl/halothane/N2O anaesthesia. Neuromuscular function was monitored mechanomyographically.
WIERDA, JMKH +4 more
openaire +1 more source
A862 G1–64, A NEW, RAPIDLY ACTING NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENT
Anesthesiology, 1990L. Gyermek, N. Nguyen, C. Lee
openaire +1 more source
The pharmacology of GW280430A: A new nondepolarizing neuromuscular blocking agent
Seminars in Anesthesia, Perioperative Medicine and Pain, 2002openaire +1 more source
Cisatracurium: a new nondepolarizing neuromuscular blocking agent.
Connecticut medicine, 1996C A, Owens, J, Brakoniecki
openaire +1 more source